there is a silent threat that affects kitties – chronic kidney disease. It is a complex and irreversible ailment that typically manifests at around 10 years old in cats, affecting an astounding 1 in 3 felines. As cats age, they gradually lose their kidney function, which significantly compromises their quality of life.
Dr. Miyazaki’s breakthrough comes in the form of the “AIM” injection. It’s a medication that has demonstrated an astounding potential to help kitties suffering from chronic kidney disease. The scientist and his team pinpointed the root cause of this treacherous ailment, which paved the way for the development of the injection.
The “AIM” injection is currently in the clinical trial phase and is anticipated to be available by 2025.
Here’s the 2016 study that started things. There are some more recent news articles in Japan from the past couple of years about the project getting funding and going into clinical trials in 2022 or 2023.
https://www.nature.com/articles/srep35251